Capital Link Greece | Investing In Greece

Results: « Previous 1 2 ... 6836 6837 6838 6839 6840 6841 6842 ... 13677 13678 Next »

Market news

NGM Biopharmaceuticals stock price target cut to $25 from $41 at B. Riley

25/05/2021 14:05 - This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news. ...

NGM Biopharmaceuticals stock price target cut to $25 from $41 at B. Riley

Waitr Holdings stock price target cut to $5 from $7 at B. Riley

Anebulo Pharmaceuticals started at buy with $15 stock price target at Benchmark

Charles River Laboratories stock price target raised to $369 from $324 at Truist

NeoGenomics stock price target cut to $54 from $65 at Truist

Ventas stock price target raised to $61 from $54 at Raymond James

Results: « Previous 1 2 ... 6836 6837 6838 6839 6840 6841 6842 ... 13677 13678 Next »

News

Market news

NGM Biopharmaceuticals stock price target cut to $25 from $41 at B. Riley

NGM Biopharmaceuticals stock price target cut to $25 from $41 at B. Riley

Waitr Holdings stock price target cut to $5 from $7 at B. Riley

Anebulo Pharmaceuticals started at buy with $15 stock price target at Benchmark

Anebulo Pharmaceuticals started at buy with $15 stock price target at Benchmark

Charles River Laboratories stock price target raised to $369 from $324 at Truist

Charles River Laboratories stock price target raised to $369 from $324 at Truist

NeoGenomics stock price target cut to $54 from $65 at Truist

NeoGenomics stock price target cut to $54 from $65 at Truist

Ventas stock price target raised to $61 from $54 at Raymond James